Delivery Order SPE2DB25D7067-SPE2DB25FSVUE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,175.85 to AmerisourceBergen Drug Corp for 100 tablets of Cipro 500 mg on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Cipro 500 mg tablets (100-count units) at a ceiling value of $1,185.69. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 14, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Cipro 500 mg tablets (100 count) at a ceiling value of $1,567.80. This competitive, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin HCL 500 mg tablets (100 count) with a contract value of $3,574.21. This competitively awarded, non-set-aside delivery order was issued on September 30, 2025, with an ultimate completion date of October 1, 2025, and reflects a firm fixed-price arrangement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Cipro 500 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $3,384.50, represents a non-competitive set-aside and is scheduled for completion by August 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 8, 2025, for Cipro 500 mg tablets (100-count) with a ceiling value of $3,275.23. This firm fixed price delivery order, which is due for completion by August 11, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cipro (ciprofloxacin) 250 mg tablets in quantities of 100 units, with a contract ceiling value of $1,564.92. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a pediatric or smaller-quantity pharmaceutical procurement utilizing AmerisourceBergen's existing contract vehicle. The award was not designated as a set-aside and...
- The Defense Logistics Agency awarded a delivery order valued at $2,351.70 to AmerisourceBergen Drug Corp for the supply of Cipro 500 mg tablets (100-count packages) under a firm fixed-price contract. The award was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and represents a non-set-aside, competitively awarded transaction. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform at its corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Cipro 500 mg tablets in quantities of 100 units. The contract is valued at $3,350.15 under a firm fixed-price structure with an ultimate completion date of September 8, 2025. This non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,549.87 to AmerisourceBergen Drug Corp for 100 tablets of Cipro 500 mg, with an ultimate completion date of July 7, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVUEDelivery Order
The Defense Logistics Agency awarded a $4,510.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Cipro 500 mg tablets in quantities of 100 units. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract is scheduled for ultimate completion on September 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor within the federal medical supply chain, AmerisourceBergen Drug Corp fulfills essential pharmaceutical procurement needs for military and veteran healthcare systems. This delivery order for the antibiotic Cipro supports DLA's mission to provide comprehensive pharmaceutical products across therapeutic domains to the Defense Health Agency and other government healthcare entities. The competitively awarded contract demonstrates AmerisourceBergen's established capability to meet federal procurement requirements and reflects the company's role as a strategic pharmaceutical prime vendor supporting global military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 9/4/25 |